Marshall Wace North America L.P. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2021$5,665,000
+177.0%
336,601
+200.5%
0.02%
+166.7%
Q1 2021$2,045,000
+58.7%
111,999
+58.2%
0.01%
+50.0%
Q4 2020$1,289,000
-90.2%
70,803
-90.4%
0.01%
-92.9%
Q3 2020$13,096,000
+55.5%
734,010
+56.2%
0.08%
+50.0%
Q2 2020$8,424,000
+15.1%
469,797
+26.6%
0.06%
+60.0%
Q4 2019$7,321,000
-17.0%
370,993
-27.7%
0.04%
-30.0%
Q3 2019$8,820,000512,8090.05%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders